{
    "2020-07-24": [
        [
            {
                "time": "2023-10-18",
                "original_text": "AbbVie Proves Masterful at Playing Drug Patent Game",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Drug",
                        "Patent",
                        "Game"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Trump signs executive order aimed at lowering drug prices",
                "features": {
                    "keywords": [
                        "Trump",
                        "executive order",
                        "lowering",
                        "drug prices"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "5 High-Yield Drug Stocks That Are Undervalued With Great Upside",
                "features": {
                    "keywords": [
                        "High-Yield",
                        "Drug Stocks",
                        "Undervalued",
                        "Upside"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Analysts Estimate AbbVie (ABBV) to Report a Decline in Earnings: What to Look Out for",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Estimate",
                        "AbbVie",
                        "Decline",
                        "Earnings"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}